Vaccine News and Research

Latest Vaccine News and Research

GTFCC launches new strategy to reduce cholera deaths by 90% by 2030

An ambitious new strategy to reduce deaths from cholera by 90% by 2030 will be launched tomorrow by the Global Task Force on Cholera Control, a diverse network of more than 50 UN and international agencies, academic institutions, and NGOs that supports countries affected by the disease.

4 Oct 2017

Five important things everyone should know about cervical cancer

There are several types of gynecologic cancers that affect the female reproductive system, including endometrial, ovarian, cervical, vaginal and vulvar cancer.

3 Oct 2017

Study finds no association between BCG vaccine and childhood asthma

Childhood asthma is a serious public health challenge in Québec and throughout the world. Although the immune mechanisms implicated in the development of childhood asthma are not fully understood, some studies seem to suggest that the BCG vaccine, used in tuberculosis prevention, may have a protective effect on childhood asthma.

3 Oct 2017

University of Hawaii researcher receives $6.3 million grant for trivalent Ebola vaccine development

University of Hawaii vaccine researcher Axel Lehrer, PhD, has received a nearly $6.3 million grant to test whether the Ebola vaccine formula he has developed will protect against two additional viruses in the same family.

28 Sep 2017

Women referred to HPV center more often have suffered from psychiatric conditions, research shows

New research from Aarhus University shows that women who are referred to an HPV center more often have had psychiatric medicine prescribed or been hospitalized for psychiatric conditions up to five years before they received the vaccine.

28 Sep 2017

Cancer vaccines need to target immune fighters that can withstand battle against malicious tumors

Cancer vaccines may need to better target T cells that can hold up to the long fight against cancer, scientists report.

27 Sep 2017

Right after Trump blamed high drug prices on campaign cash, drugmakers gave more

"The cost of medicine in this country is outrageous," President Donald Trump said at a rally in Louisville, Ky., two months after his inauguration. He went on about how identical pills have vastly lower price tags in Europe.

27 Sep 2017

California scrambles to contain ‘unprecedented’ hepatitis A outbreaks

Health officials in California are struggling to contain fierce outbreaks of hepatitis A among homeless people and drug abusers in three counties, including San Diego, where at least 17 people have died.

26 Sep 2017

Potential Zika vaccine blocks mother-to-fetus transmission and stops male testis infection

For the first time, a collaborative team led by The University of Texas Medical Branch at Galveston has shown that a potential Zika vaccine quickly can protect fetuses against infection as well as protect males against testicular infection and injury.

26 Sep 2017

MIT study sheds light on flu viruses' rapid evolution

Influenza viruses mutate rapidly, which is why flu vaccines have to be redesigned every year. A new study from MIT sheds light on just how these viruses evolve so quickly and offers a potential way to slow them down.

26 Sep 2017

Experts continue to recommend that all pregnant women receive a flu shot

The president of the American College of Obstetricians and Gynecologists (ACOG) has released a statement recommending that all pregnant women receive a flu shot during any trimester of their pregnancy.

26 Sep 2017

Vaccine to prevent Lyme disease on the cards

Lyme disease is an infection that spreads with the bites of an infected tick. For the past four years, a vaccine to protect dogs from this disease has been available. Now, vaccinating humans against this disease has also become a possibility.

26 Sep 2017

Study: Antibody neutralizes dengue and Zika virus in mice

Brazil and other areas hardest hit by the Zika virus – which can cause babies to be born with abnormally small heads – are also home to dengue virus, which is spread by the same mosquito species.

25 Sep 2017

Study identifies two genes involved in invasive group A Streptococcus infections

Group A Streptococcus bacteria cause a variety of illnesses that range from mild nuisances like strep throat to life-threatening conditions including pneumonia, toxic shock syndrome and the flesh-eating disease formally known as necrotizing fasciitis.

22 Sep 2017

Triple-action antibody to be tested as HIV vaccine

Scientists from the National Institutes of Health (NIH) in collaboration with the pharmaceutical company Sanofi have engineered a three-pronged antibody that protected monkeys from two strains of Human Immunodeficiency Virus (HIV) better than the equivalent naturally occurring antibodies.

22 Sep 2017

Experts advise new measures to combat antimicrobial resistance

An expert panel was formed in the United States to advise the government on how to deal with the problem of antimicrobial resistance (AMR), a growing menace. This panel has now come up with a set of recommendations that could help reduce AMR in humans and animals. Recommendations include development of new vaccines against infections, development of better diagnostic tools to detect the infections early and also new therapies to handle the infections.

22 Sep 2017

Global resurgence of whooping cough can be attributed to immunological failures of vaccines

The startling global resurgence of pertussis, or whooping cough, in recent years can largely be attributed to the immunological failures of acellular vaccines, Boston University School of Public Health researchers argue in a new journal article.

21 Sep 2017

New study shows how staph cells evade the body's immune system

For years, medical investigators have tried and failed to develop vaccines for a type of staph bacteria associated with the deadly superbug MRSA. But a new study by Cedars-Sinai investigators shows how staph cells evade the body's immune system, offering a clearer picture of how a successful vaccine would work.

21 Sep 2017

High-dose flu vaccine could protect middle-aged adults with chronic conditions

Expanding the high-dose influenza vaccine recommendation to include middle-aged adults with chronic health conditions may make economic sense and save lives, report scientists at the University of Pittsburgh School of Medicine.

21 Sep 2017

Study identifies slowly proliferating and highly invasive melanoma cells

A study conducted at The Wistar Institute has led to the identification of a slowly proliferating and highly invasive melanoma cell subpopulation, characterized by production of a protein associated with invasive behavior. The research was published in the journal Oncogene.

21 Sep 2017